Background: Tricuspid valve surgery has been the de facto standard treatment for tricuspid valve endocarditis (TVE) refractory to medical therapy. It is now possible to remove right-sided vegetations percutaneously using a venous drainage cannula with an extracorporeal bypass circuit.
Objectives: The purpose of our study is to describe our single-center experience of percutaneous tricuspid valve vegetation removal.
Background: There is a paucity of data on the use of induction immunosuppression in patients with active infections undergoing orthotopic heart transplantation (OHT). We hypothesized that induction immunosuppression in patients with ventricular assist device (VAD) undergoing OHT with localized active driveline infection (DLI) does not lead to worse outcomes.
Materials And Methods: We retrospectively analyzed our database for bridge-to-transplant VAD patients who underwent OHT and received induction therapy.